2021. Cardiotoxicity with doxorubicin, trastuzumab, and development of the metabolic syndrome: Case report. Research, Society and Development. 10, 5 (May 2021), e46910515037. DOI:https://doi.org/10.33448/rsd-v10i5.15037.